Teladoc Health, Inc. (NYSE:TDOC) Shares Acquired by Geode Capital Management LLC

Geode Capital Management LLC increased its stake in Teladoc Health, Inc. (NYSE:TDOC) by 1.5% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,925,167 shares of the health services provider’s stock after purchasing an additional 56,864 shares during the quarter. Geode Capital Management LLC owned approximately 2.28% of Teladoc Health worth $36,042,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also made changes to their positions in the company. Signaturefd LLC boosted its position in Teladoc Health by 148.7% during the 2nd quarter. Signaturefd LLC now owns 2,868 shares of the health services provider’s stock worth $28,000 after acquiring an additional 1,715 shares during the period. International Assets Investment Management LLC acquired a new stake in shares of Teladoc Health during the second quarter worth approximately $29,000. Blue Trust Inc. grew its position in Teladoc Health by 84.5% during the third quarter. Blue Trust Inc. now owns 4,048 shares of the health services provider’s stock valued at $40,000 after purchasing an additional 1,854 shares in the last quarter. Doheny Asset Management CA acquired a new position in Teladoc Health in the 2nd quarter valued at approximately $46,000. Finally, Benjamin F. Edwards & Company Inc. increased its stake in Teladoc Health by 209.8% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 5,015 shares of the health services provider’s stock valued at $49,000 after buying an additional 3,396 shares during the period. 76.82% of the stock is owned by hedge funds and other institutional investors.

Teladoc Health Stock Up 1.5 %

Shares of TDOC stock opened at $9.26 on Thursday. Teladoc Health, Inc. has a 12 month low of $6.76 and a 12 month high of $22.54. The company has a quick ratio of 1.69, a current ratio of 1.73 and a debt-to-equity ratio of 0.66. The firm has a market cap of $1.59 billion, a PE ratio of -1.60 and a beta of 0.97. The stock has a 50 day moving average of $9.84 and a 200-day moving average of $9.08.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings results on Wednesday, October 30th. The health services provider reported ($0.19) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.29) by $0.10. Teladoc Health had a negative net margin of 37.91% and a negative return on equity of 10.06%. The firm had revenue of $640.51 million during the quarter, compared to the consensus estimate of $630.50 million. On average, equities analysts predict that Teladoc Health, Inc. will post -1.16 EPS for the current year.

Insider Activity at Teladoc Health

In other Teladoc Health news, insider Carlos Nueno sold 2,389 shares of Teladoc Health stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $11.93, for a total transaction of $28,500.77. Following the sale, the insider now owns 2,890 shares in the company, valued at $34,477.70. The trade was a 45.25 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.95% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently commented on the stock. Piper Sandler restated an “overweight” rating and set a $13.00 price target (up from $11.00) on shares of Teladoc Health in a report on Wednesday, December 4th. TD Cowen lowered their target price on Teladoc Health from $9.00 to $8.00 and set a “hold” rating on the stock in a research note on Thursday, October 31st. Royal Bank of Canada raised their price target on Teladoc Health from $9.00 to $10.00 and gave the stock an “outperform” rating in a research note on Wednesday, October 9th. Evercore ISI boosted their price target on Teladoc Health from $8.00 to $9.00 and gave the company an “in-line” rating in a research note on Tuesday, October 8th. Finally, The Goldman Sachs Group started coverage on shares of Teladoc Health in a research report on Friday, November 15th. They set a “buy” rating and a $14.00 price objective on the stock. Fourteen research analysts have rated the stock with a hold rating and seven have issued a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $12.24.

Teladoc Health Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.